Essais liés3clinical trials
VilleStockholmlocalisation
PaysSwedenlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06544616

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
JNJ-64042056 Alzheimer Phase 2 NCT06544616 Reτain — A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease ACTIVE_NOT_RECRUITING
Ocrelizumab SEP Phase 3 NCT05269004 OLERO — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis ACTIVE_NOT_RECRUITING
Interferon beta-1a SEP Phase 3 NCT01412333 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis COMPLETED